Healthcare provider profile · identity verified

Timothy A Randall, MD

Family Practice · LONGVIEW, WA · NPI 1245237262

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	586	150
Levothyroxine Sodium	Levothyroxine Sodium	530	109
Amlodipine Besylate	Amlodipine Besylate	463	97
Furosemide	Furosemide	423	82
Lisinopril	Lisinopril	408	92
Potassium Chloride	Potassium Chloride	346	74
Losartan Potassium	Losartan Potassium	313	64
Pantoprazole Sodium	Pantoprazole Sodium	305	63
Gabapentin	Gabapentin	297	71
Tamsulosin Hcl	Tamsulosin Hcl	277	61
Rosuvastatin Calcium	Rosuvastatin Calcium	271	61
Metoprolol Succinate	Metoprolol Succinate	253	76
Metoprolol Tartrate	Metoprolol Tartrate	246	61
Eliquis	Apixaban	232	50
Duloxetine Hcl	Duloxetine Hcl	196	37
Warfarin Sodium	Warfarin Sodium	178	18
Sertraline Hcl	Sertraline Hcl	176	45
Metformin Hcl Er	Metformin Hcl	172	36
Metformin Hcl	Metformin Hcl	169	46
Omeprazole	Omeprazole	162	59
Trazodone Hcl	Trazodone Hcl	149	38
Carvedilol	Carvedilol	147	26
Mirtazapine	Mirtazapine	145	34
Simvastatin	Simvastatin	141	33
Lantus	Insulin Glargine,hum.Rec.Anlog	138	28
Clopidogrel	Clopidogrel Bisulfate	133	31
Oxycodone Hcl	Oxycodone Hcl	123	47
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	120	30
Jardiance	Empagliflozin	117	23
Hydrochlorothiazide	Hydrochlorothiazide	113	30
Lovastatin	Lovastatin	106	28
Albuterol Sulfate Hfa	Albuterol Sulfate	105	53
Glipizide	Glipizide	94	19
Allopurinol	Allopurinol	89	25
Isosorbide Mononitrate Er	Isosorbide Mononitrate	89	18
Memantine Hcl	Memantine Hcl	85	16
Risperidone	Risperidone	84	15
Famotidine	Famotidine	80	20
Buspirone Hcl	Buspirone Hcl	74	16
Donepezil Hcl	Donepezil Hcl	74	18
Levetiracetam	Levetiracetam	72	16
Tizanidine Hcl	Tizanidine Hcl	72	16
Citalopram Hbr	Citalopram Hydrobromide	69	14
Ropinirole Hcl	Ropinirole Hcl	69	14
Pravastatin Sodium	Pravastatin Sodium	68	17
Escitalopram Oxalate	Escitalopram Oxalate	66	13
Ezetimibe	Ezetimibe	65	18
Alendronate Sodium	Alendronate Sodium	60	15
Fluticasone Propionate	Fluticasone Propionate	59	25
Quetiapine Fumarate	Quetiapine Fumarate	58	17
Spironolactone	Spironolactone	58	11
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	57	14
Ondansetron Odt	Ondansetron	57	12
Oxybutynin Chloride	Oxybutynin Chloride	53	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	53	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	52	13
Azithromycin	Azithromycin	49	24
Lidocaine	Lidocaine	49	18
Finasteride	Finasteride	48	14
Myrbetriq	Mirabegron	48	suppressed
Baclofen	Baclofen	47	11
Hydralazine Hcl	Hydralazine Hcl	47	11
Insulin Glargine-Yfgn	Insulin Glargine-Yfgn	46	17
Divalproex Sodium Er	Divalproex Sodium	45	suppressed
Lactulose	Lactulose	44	suppressed
Montelukast Sodium	Montelukast Sodium	44	17
Amitriptyline Hcl	Amitriptyline Hcl	43	suppressed
Bupropion Xl	Bupropion Hcl	43	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	43	suppressed
Morphine Sulfate Er	Morphine Sulfate	43	suppressed
Glipizide Er	Glipizide	42	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	42	31
Propranolol Hcl	Propranolol Hcl	42	11
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	41	16
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	39	31
Cephalexin	Cephalexin	39	28
Lamotrigine	Lamotrigine	39	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	39	16
Tramadol Hcl	Tramadol Hcl	39	18
Atenolol	Atenolol	36	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	36	17
Prednisone	Prednisone	36	19
Acetic Acid	Acetic Acid	33	suppressed
Trulicity	Dulaglutide	33	suppressed
Bupropion Hcl Sr	Bupropion Hcl	32	suppressed
Bupropion Hcl	Bupropion Hcl	31	suppressed
Irbesartan	Irbesartan	31	suppressed
Lorazepam	Lorazepam	30	suppressed
Morphine Sulfate	Morphine Sulfate	30	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	29	22
Latanoprost	Latanoprost	29	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	29	suppressed
Xifaxan	Rifaximin	29	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	27	suppressed
Roflumilast	Roflumilast	27	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Diazepam	Diazepam	25	suppressed
Nitroglycerin	Nitroglycerin	25	15
Cefdinir	Cefdinir	24	17
Chlorthalidone	Chlorthalidone	24	suppressed
Methocarbamol	Methocarbamol	24	16
Olmesartan Medoxomil	Olmesartan Medoxomil	24	suppressed
Spiriva Respimat	Tiotropium Bromide	24	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	23	suppressed
Midodrine Hcl	Midodrine Hcl	23	suppressed
Ozempic	Semaglutide	23	suppressed
Albuterol Sulfate	Albuterol Sulfate	22	suppressed
Nystatin	Nystatin	22	13
Oxybutynin Chloride Er	Oxybutynin Chloride	22	suppressed
Primidone	Primidone	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	11
Diclofenac Sodium	Diclofenac Sodium	21	11
Ketoconazole	Ketoconazole	21	suppressed
Digoxin	Digoxin	20	11
Humalog	Insulin Lispro	20	suppressed
Pentoxifylline	Pentoxifylline	20	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	20	suppressed
Bumetanide	Bumetanide	19	suppressed
Calcitriol	Calcitriol	19	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	19	suppressed
Xarelto	Rivaroxaban	19	suppressed
Divalproex Sodium	Divalproex Sodium	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Colesevelam Hcl	Colesevelam Hcl	17	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	17	suppressed
Incruse Ellipta	Umeclidinium Bromide	17	suppressed
Carbidopa-Levodopa Er	Carbidopa/Levodopa	16	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	16	suppressed
Trimethoprim	Trimethoprim	16	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	15	suppressed
Meloxicam	Meloxicam	15	suppressed
Admelog	Insulin Lispro	14	suppressed
Alprazolam	Alprazolam	14	suppressed
Klayesta	Nystatin	14	11
Levofloxacin	Levofloxacin	14	suppressed
Nifedipine Er	Nifedipine	14	suppressed
Olanzapine	Olanzapine	14	suppressed
Paroxetine Hcl	Paroxetine Hcl	14	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	14	suppressed
Ranolazine Er	Ranolazine	14	suppressed
Sucralfate	Sucralfate	14	suppressed
Farxiga	Dapagliflozin Propanediol	13	suppressed
Lagevrio (Eua)	Molnupiravir	13	13
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	13	suppressed
Ursodiol	Ursodiol	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	12	suppressed
Bicalutamide	Bicalutamide	12	suppressed
Brimonidine Tartrate	Brimonidine Tartrate	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Gentamicin Sulfate	Gentamicin Sulfate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Insulin Lispro	Insulin Lispro	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Leflunomide	Leflunomide	11	suppressed
Lidocaine Hcl	Lidocaine Hcl	11	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	11	suppressed
Topiramate	Topiramate	11	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error